The relative ratio of p-EGFR to total EGFR showed significant decreases in the ERL and CIS individual treatments, and the converse in the combination groups, with significant upregulation seen in the PPL and ERL group (113%) (Fig. 4H), compared to the control. This evidence concerns the gene EGFR and in situ carcinoma.